Metabolic screening and metabolomics analysis in the Intellectual Developmental Disorders Mexico Study.

OBJECTIVE Inborn errors of metabolism (IEM) are genetic conditions that are sometimes associated with intellectual developmental disorders (IDD). The aim of this study is to contribute to the metabolic characterization of IDD of unknown etiology in Mexico. MATERIALS AND METHODS Metabolic screening using tandem mass spectrometry and fluorometry will be performed to rule out IEM. In addition, target metabolomic analysis will be done to characterize the metabolomic profile of patients with IDD. CONCLUSION Identification of new metabolomic profiles associated with IDD of unknown etiology and comorbidities will contribute to the development of novel diagnostic and therapeutic schemes for the prevention and treatment of IDD in Mexico.

• Publication year

  2017

• Venue

  Salud Pública de México

• Publication date

  2017-07-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.21149/8668PMID 29211263
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnosing childhood-onset inborn errors of metabolism by next-generation sequencing

  2017cited by this paper
• Screening for inherited metabolic diseases using gas chromatography-tandem mass spectrometry (GC-MS/MS) in Sichuan, China.

  2017cited by this paper
• The intellectual developmental disorders Mexico study: situational diagnosis, burden, genomics and intervention proposal.

  2016cited by this paper
• The investigation of inborn errors of metabolism as an underlying cause of idiopathic intellectual disability in adults in Norway

  2016cited by this paper
• Potential serum biomarkers from a metabolomics study of autism.

  2016cited by this paper
• Clinical Metabolomics: The New Metabolic Window for Inborn Errors of Metabolism Investigations in the Post-Genomic Era

  2016cited by this paper
• Technological Journey From Colorimetric to Tandem Mass Spectrometric Measurements in the Diagnostic Investigation for Phenylketonuria

  2016cited by this paper
• [Methodological bases and implementation results of Mexico's National Survey of Children and Women 2015].

  2016cited by this paper
• Using MetaboAnalyst 3.0 for Comprehensive Metabolomics Data Analysis

  2016cited by this paper
• Fifty years of newborn screening

  2015cited by this paper
• Retrospective analysis supports algorithm as efficient diagnostic approach to treatable intellectual developmental disabilities.

  2015cited by this paper
• Plasma N-Glycome Signature of Down Syndrome.

  2015cited by this paper
• Current status of newborn screening worldwide: 2015.

  2015cited by this paper
• Fifty years of newborn screening.

  2014cited by this paper
• Caracterización de errores innatos del metabolismo intermediario en pacientes mexicanos

  2014cited by this paper
• The metabolic evaluation of the child with an intellectual developmental disorder: diagnostic algorithm for identification of treatable causes and new digital resource.

  2014cited by this paper
• [Characterization of inborn errors of intermediary metabolism in mexican patients].

  2014cited by this paper
• Metabolomics in chronic kidney disease.

  2013cited by this paper
• Targeted Metabolomics

  2012cited by this paper
• Schizophrenia shows a unique metabolomics signature in plasma

  2012cited by this paper
• Interactome networks and human disease.

  2011cited by this paper
• Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks

  2011cited by this paper
• Public health research on rare diseases.

  2011cited by this paper
• Neurometabolic disorders

  2009cited by this paper
• Variabilidad interinstitucional del tamiz neonatal en México

  2009cited by this paper
• Mental retardation and inborn errors of metabolism

  2009cited by this paper
• Neurometabolic disorders

  2008cited by this paper
• Electrospray tandem mass spectrometry for analysis of acylcarnitines in dried postmortem blood specimens collected at autopsy from infants with unexplained cause of death.

  2001cited by this paper
• MENTAL RETARDATION AND THE INBORN ERRORS OF METABOLISM.

  1964cited by this paper
• Interactome Networks and Human Disease

  year unknowncited by this paper

• Tandem mass spectrometry in screening for inborn errors of metabolism: comprehensive bibliometric analysis

  2025cites this paper
• Need and Challenges in Establishing Newborn Screening Programs for Inherited Metabolic Disorders in Developing Countries

  2023cites this paper
• Identification of three novel pathogenic mutations in cystathionine beta-synthase gene of Pakistani intellectually disabled patients

  2021cites this paper
• High levels of blood glutamic acid and ornithine in children with intellectual disability

  2020cites this paper
• Brief Report: Delayed Diagnosis of Treatable Inborn Errors of Metabolism in Children with Autism and Other Neurodevelopmental Disorders

  2020cites this paper
• Brief Report: Delayed Diagnosis of Treatable Inborn Errors of Metabolism in Children with Autism and Other Neurodevelopmental Disorders

  2020cites this paper
• Nitric oxide production is downregulated during respiratory syncytial virus persistence by constitutive expression of arginase 1

  2019cites this paper
• Biochemical Screening of Intellectually Disabled Patients: A Stepping Stone to Initiate a Newborn Screening Program in Pakistan

  2019cites this paper
• Biochemical screening of intellectually disabled and healthy children in Punjab, Pakistan: differences in liver function test and lipid profiles

  2019cites this paper